Catalogue illustration · 200 mg
Research material
NAD+
Mitochondrial & longevity
3 mL pen · 200 mg
Nicotinamide adenine dinucleotide itself — a redox cofactor central to energy metabolism and a substrate for sirtuins and PARPs. A molecule, not a peptide.
Supplied for laboratory research use only. Not for human or animal consumption. Price is per pen, EU delivery included.
- Total fill
- 200 mg
- Format
- 3 mL pen
- Material
- Non-peptide
- Purpose
- Laboratory research
01 — The format
The catalogue format.
NAD+ is listed as 200 mg in a 3 mL pre-filled pen. The listed quantity is total content per pen, not an administration dose.
The catalogue format does not establish concentration accuracy, stability or delivered volume. These require product-specific documentation.
No reconstitution, dosing or application instructions are supplied. Request the material specification and lot documentation for your laboratory review.
02 — The sequence
Molecular identity.
Nicotinamide adenine dinucleotide itself — a redox cofactor central to energy metabolism and a substrate for sirtuins and PARPs. A molecule, not a peptide.
Reference sequence: Not applicable — this compound is not a peptide.
The research description does not establish clinical effectiveness or authorisation of this Aevamere product.
A compound-specific primary-source review is not yet published here. The description above comes from the existing catalogue; it is not a batch certificate.
Reference, not verification. Reference descriptions concern the named compound. They do not verify the contents, purity, biological activity or safety of a supplied batch.
03 — Specification
Analytical data and documentation.
- Compound
- NAD+
- Catalogue fill
- 200 mg
- Format
- 3 mL pre-filled pen, as listed in the catalogue
- Reference sequence
- Not applicable — this compound is not a peptide.
- Molecular formula / mass
- Not verified for the supplied form — request the product specification.
- Salt / counterion
- Not published for this product.
- Batch / lot
- Not available on this page.
- Measured purity
- Not available — no product-matched analytical report has been provided.
- Identity result
- Not available — reference identity is not a measured batch result.
- Endotoxin / sterility
- Not available — no product-matched results have been provided.
- Storage / expiry
- Consult the product-specific label and supporting stability documentation; not verified here.
04 — Batch documentation
Batch results not published.
No verified, product-matched batch report is available on this page. Purity, identity, endotoxin and sterility results are not inferred from the compound name or another product.
Chromatography and mass spectrometry are examples of analytical approaches. The appropriate methods depend on the material; naming a method is not evidence that testing was performed.
Request the specific lot and its supporting reports
Request documentation05 — Handling
Supplied as laboratory research material.
NAD+ is sold for in-vitro and analytical research use. This page does not establish marketing authorisation and gives no usage, dosing or application guidance of any kind.
- For in-vitro and analytical laboratory research use only
- Not for human or animal consumption
- Not for clinical, diagnostic, therapeutic or cosmetic use
- Follow product-specific documentation and your laboratory procedures
- No dosing or administration guidance is provided
06 — What arrives
In the box.
- Catalogue format: one 3 mL pen · 200 mg.
- Confirm packaging, accessories and documentation with the supplier before ordering.
- Batch certificates, storage records and expiry documentation have not been published on this page.
07 — Questions
About this sequence specifically.
- What quantity does this page describe?
- 200 mg per 3 mL pen. This is a catalogue quantity, not dosing guidance.
- Is the sequence a batch test?
- Not applicable — this compound is not a peptide.
- Where are the analytical results?
- No product-matched certificate is published here. Request the lot number, methods, results and acceptance criteria before evaluating the material.
- Does a medicine approval apply to this pen?
- The research description does not establish clinical effectiveness or authorisation of this Aevamere product.
The rest of the collection
Held to the same standard.
Accounts & bulk supply
Ask about this material.
For availability, product specifications, batch documentation or bulk quantities, tell us what your laboratory requires.
